Following the launch of its initiative, "Pharmaceutical cGMPs for the 21st Century: A Risk-Based Approach," FDA has been looking to process analytical technology (PAT) for improvements in process ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback